IL6 and endothelial dysfunction: Pro-inflammatory agents like tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), and vascular endothelial growth factors can further exacerbate vascular injury and endothelial dysfunction, leading to vascular remodeling (42).